Rigel Pharmaceuticals Inc vs Tencent Holdings Ltd ADR
A head-to-head of Rigel Pharmaceuticals Inc (RIGL) and Tencent Holdings Ltd ADR (TCEHY) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | RIGL | TCEHY |
|---|---|---|
| Market Cap | $564.75M | $547.50B |
| P/E (TTM) | 1.50 | 16.92 |
| Forward P/E | 6.45 | 13.76 |
| P/S | 1.92 | 0.73 |
| P/B | 1.41 | 3.28 |
| EV/EBITDA | 3.51 | 10.52 |
| Dividend Yield | — | 1.12% |
| Profit Margin | 124.72% | 29.90% |
| Gross Margin | 93.33% | 56.21% |
| Operating Margin | 42.63% | 32.56% |
| Revenue Growth (YoY) | +21.19% | +11.16% |
| FCF Yield | 13.40% | — |
| Debt / Equity | 13.51 | 34.04 |
| Current Ratio | 2.42 | 1.44 |
Share:
Compare Rigel Pharmaceuticals Inc with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.